Characterization of the inflammatory response to proteinase-activated receptor-2 (PAR2)-activating peptides in the rat paw

British Journal of Pharmacology

Volumn 127, Issue 5, 1999, Pages 1083-1090

  Vergnolle, Nathalie ^a   Hollenberg, Morley D ^a   Sharkey, Keith A ^a   Wallace, John L ^a,b  

^a UNIVERSITY OF CALGARY   (Canada)

^b UNIVERSITY OF CALGARY   (Canada)

Author keywords

Inflammation; Mast cell; Nitric oxide; Oedema; PAR2; Prostaglandin; Proteinase activated receptor

Indexed keywords

ARGININE METHYL ESTER; COMPOUND 48-80; CROMOGLYCATE DISODIUM; INDOMETACIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; GRANULOCYTE; INFLAMMATION; INFLAMMATORY CELL; INFLAMMATORY INFILTRATE; NONHUMAN; PAW EDEMA; PRIORITY JOURNAL; RAT;

EID: 0032792955     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0702634     Document Type: Article

References (29)

1. 2 in rat vascular and gastric smooth muscle. Can. J. Physiol. Pharmacol., 73, 1203-1207.
2. CIRINO, G., CICALA, C., BUCCI, M.R., SORRENTINO, L., MARAGANORE, J.M. & STONE, S.R. (1996). Thrombin functions as an inflammatory mediator through activation of its receptor. J. Exp. Med., 183, 821-827.
3. CORVERA, C.U., DERY, O., MCCONALOGUE, K., BOHM, S.K., KHITIN, L.M., CAUGHEY, G.H., PAYAN, D.G. & BUNNETT, N.W. (1997). Mast cell tryptase regulates colonic myocytes through proteinase-activated receptor-2. J. Clin. Invest., 100, 1383-1393.
4. DI ROSA, M., GIROUD, J.P. & WILLOUGHBY, D.A. (1971). Studies of the mediators of the acute inflammatory response induced in rats at different sites by carrageenan and turpentine. J. Pathol., 104, 15-29.
5. EMILSSON, K., WAHLESTEDT, C., SUN, M.K., NYSTEDT, S., OWMAN, C. & SUNDELIN, J. (1997). Vascular effects of proteinase-activated receptor 2 agonist peptide. J. Vasc. Res., 34, 267-272.
6. FOX, M.T., HARRIOTT, P., WALKER, B. & STONE, S.R. (1997). Identification of potential activators of proteinase-activated receptor-2. FEBS Lett., 417, 267-269.
7. HOLLENBERG, M.D., SAIFEDDINE, M., AL-ANI, B. & KAWABATA, A. (1997). Proteinase-activated receptors: structural requirements for activity, receptor cross-reactivity, and receptor selectivity of receptor-activating peptides. Can. J. Physiol. Pharmacol., 75, 832-841.
8. HONORE, P., CHAPMAN, V., BURITOVA, J. & BESSON, J.M. (1995). Reduction of carrageenin oedema and the associated c-Fos expression in the rat lumbar spinal cord by nitric oxide synthase inhibitor. Br. J. Pharmacol., 114, 77-74.
9. HOWELLS, G.L., MACEY, M., CHINNI, C., HOU, L., FOX, M.T., HARRIOTT, P. & STONE, S. (1997). Proteinase-activated receptor-2: expression by human neutrophils. J. Cell. Sci., 110, 881-887.
10. HWA, J.J., GHIBAUDI, L., WILLIAMS, P., CHINTALA, M., ZHANG, R., CHATTERJEE, M. & SYBERTZ, E. (1996). Evidence for the presence of proteinase-activated receptor distinct from the thrombin receptor in vascular endothelial cells. Circ. Res., 78, 581-588.
11. ISHIHARA, H., CONNOLLY, A.J., ZENG, D., KAHN, M.L., ZHENG, Y.W., TIMMONS, C., TRAM, T. & COUGHLIN, S.R. (1997). Proteinase-activated receptor 3 is a second thrombin receptor in humans. Nature, 386, 502-506.
12. KAHN, M.L., ZHENG, Y.W., HUANG, W., BIGORNIA, V., ZENG, D., MOFF, S., FARESE JR, R.V., TAM, C. & COUGHLlN, S.R. (1998). A dual thrombin receptor system for platelet activation. Nature, 394, 690-694.
13. KAWABATA, A., KURODA, R., MINAMI, T., KATAOKA, K. & TANEDA, M. (1998). Increased vascular permeability by a specific agonist of protease-activated receptor-2 in rat hindpaw. Br. J. Pharmacol., 125, 419-422.
14. KONG, W., MCCONALOGUF, K., KHITIN, L.M., HOLLENBERG, M.D., PAYAN, D.G., BOHM, S.K. & BUNNETT, N.W. (1997). Luminal trypsin may regulate enterocytes through proteinase-activated receptor 2. Proc. Acad. Natl. Sci. U.S.A., 94, 8884-8889.
15. MARTEL, R.R. & KLICIUS, J. (1994). Reagin-mediated hypersensitivity reaction in the rat hindpaw and its inhibition by antianaphylactic drugs. Int. Arch. Allergy Appl. Imnumol., 54, 205-209.
16. 2) mediates mitogenic responses in human vascular endothelial cells. J. Clin. Invest., 97, 1705-1714.
17. MOLINO, M., BARNATHAN, E.S., NUMEROF, R., CLARK, J., DREYER, M., CUMASHI, A., HOXIE, J.A., SCHECHTER, J.A., WOOLKALIS, M. & BRASS, L.F. (1997). Interaction of mast cell tryptase with thrombin receptors and PAR-2. J. Biol. Chem., 272, 4043-4049.
18. MOUSLI, M., BUEB, J.L., BRONNER, C., ROUOT, B. & LANDRY, Y. (1990). G-protein activation: a receptor-independent mode of action for cationic amphiphilic ncuropeptides and venom peptides. Trends Pharmacol. Sci., 11, 358-362.
19. NYSTEDT, S., EMILSSON, K., WAHLESTEDT, C. & SUNDELIN, J. (1994). Molecular cloning of a potential proteinase activated receptor. Proc. Natl. Acad. Sci. U.S.A., 91, 9208-9212.
20. NYSTEDT, S., RAMAKRISHNAN, V. & SUNDELIN, J. (1996). The proteinase-activated receptor 2 is induced by inflammatory mediators in human endothelial cells. J. Biol. Chem., 271, 14910-14915.
21. 2+ mobilization. FEBS Lett., 288, 123-128.
22. SAIFEDDINE, M., AL-ANI, B., CHENG, C.H., WANG, L. & HOLLENBERG, M.D. (1996). Rat proteinase-activated receptor-2 (PAR-2): cDNA sequence and activity of receptor-derived peptides and in gastric and vascular tissues. Br. J. Pharmacol., 118, 521-530.
23. SAIFEDDINE, M., ROY, S.S., AL-ANI, B., TRIGGLE, C.R. & HOLLENBERG, M.D, (1998). Endothelium-dependent contractile actions of proteinase-activated receptor-2-activating peptides in human umbilical vein: release of a contracting factor via a novel receptor. Br. J. Pharmacol., 125, 1445-1454.
24. VERGNOLLE, N., HOLLENBERG, M.D. & WALLACE, J.L. (1999). Pro- and anti-inflammatory actions of thrombin: a distinct role for proteinase-activated receptor-1 (PAR-I). Br. J. Pharmacol., 126, 1262-1268.
25. VERGNOLLE, N., NAUGHTON, W.K., AL-ANI, B., SAIFEDDINE, M., WALLACE, J.L. & HOLLENBERG, M.D. (1998). Proteinase-activated receptor-2-activating peptides: identification of a receptor that regulates intestinal transport. Proc. Natl. Acad. Sci. U.S.A., 95, 7766-7771.
26. VU, T.K., HUNG, D.T., WHEATON, V.I. & COUGHLIN, S.R. (1991). Molecular cloning of a functional thrombin receptor reveals a novel proteolytic mechanism of receptor activation. Cell, 64, 1057-1068.
27. WALLACE, J.L., CHAPMAN, K. & MCKNIGHT, W. (1999). Limited anti-inflammatory efficacy of cyclooxygenase-2 inhibition in carrageenan-airpouch inflammation. Br. J. Pharmacol., 126, 1200-1205.
28. WINTER, C.A., RISLEY, E.A. & NUSS, G.W. (1962). Carrageenan-induced oedema in the hind paw of the rat as an assay for anti-inflammatory drugs. Proc. Soc. Exp. Biol. Med., 111, 544-547.
29. XU, W., ANDERSEN, H., WHITMORE, T.E., PRESNELL, S.R., YEE, D.P., CHING, A., GILBERT, T., DAVIE, E.W. & FOSTER, D.C. (1998). Cloning and characterization of human protease-activated receptor 4. Proc. Natl. Acad. Sci. U.S.A., 95, 6642-6646.